Morristown Medical Center First in New Jersey to Offer Nonsurgical Ablation Technique for Advanced Lung Cancer - Report - MDSpire
Advertisement
Morristown Medical Center First in New Jersey to Offer Nonsurgical Ablation Technique for Advanced Lung Cancer
Atlantic Health’s Morristown Medical Center is the first hospital in New Jersey to offer patients a new, minimally invasive option to treat advanced lung cancer. The procedure couples technology from the Aliya™ Pulsed Electric Field (PEF) Energy Platform with a robotic Ion Bronchoscopy.
Clinical Report: Morristown Medical Center First in NJ to Offer Nonsurgical Ablation
Overview
Morristown Medical Center has introduced a pioneering nonsurgical ablation technique for advanced lung cancer using the Aliya™ Pulsed Electric Field (PEF) Energy Platform combined with robotic bronchoscopy. This minimally invasive procedure offers a safer alternative to traditional thermal ablation methods, reducing risks associated with surgery and radiation.
Background
The management of advanced lung cancer presents significant challenges, particularly for patients who are not candidates for surgery or radiation. Innovative treatment options are essential to improve patient outcomes and quality of life. The introduction of the Aliya™ PEF Energy Platform represents a significant advancement in lung cancer care, providing a less invasive approach to tumor ablation.
Data Highlights
No numerical data provided in the source material.
Key Findings
Morristown Medical Center is the first in New Jersey to offer the Aliya™ PEF Energy Platform for lung cancer treatment.
The procedure is minimally invasive and can be performed as a same-day outpatient treatment.
Aliya™ PEF technology uses high-voltage electrical pulses to ablate tumors at lower temperatures, minimizing damage to surrounding tissues.
This technique reduces inflammation and lowers the risk of complications such as lung collapse and bleeding.
Robotic bronchoscopy enhances access to difficult-to-reach areas of the lung for effective treatment.
Clinical Implications
The introduction of the Aliya™ PEF Energy Platform allows for a personalized approach to lung cancer treatment, particularly for patients who are not suitable for traditional therapies. Clinicians should consider this option as part of a multidisciplinary care strategy for advanced lung cancer patients.
Conclusion
The adoption of the Aliya™ PEF Energy Platform at Morristown Medical Center marks a significant step forward in the treatment of advanced lung cancer, offering a promising alternative to conventional methods. Continued innovation in cancer care is crucial for improving patient outcomes.